At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Intrathecal Autologous Stem Cellsprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intrathecal Autologous Stem Cells for Children With Hipoxic/Ischemic Brain Injury
In Brief
A clinical study evaluating Intrathecal Autologous Stem Cells for Hypoxia-Ischemia, Cerebral and Cerebral Palsy. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether the plasticity of autologous intrathecal hematopoietic cells would improve the neurologic evolution of the pediatric patients with hypoxic/ischemic brain injury.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypoxia-Ischemia, Cerebral, Cerebral Palsy
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedNov 2009
Primary CompletionApr 2010
Study CompletionJan 2011
TodayJul 2026
First PostedNov 25, 2009
Enrollment StartJul 1, 2009
Primary CompletionApr 1, 2010
Study CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.6 years ago
Interventions
Intrathecal Autologous Stem Cellsprocedure
Patients will be stimulated with Granulocyte Colony Stimulating Factor (G-CSF) 5 times, harvest bone marrow and infused 8 to 10 mL of stem cells (CD34+) by intrathecal via.